LV11899A - Jauni adenozina atvasinajumi to iegusanas panemiens - Google Patents

Jauni adenozina atvasinajumi to iegusanas panemiens

Info

Publication number
LV11899A
LV11899A LV970128A LV970128A LV11899A LV 11899 A LV11899 A LV 11899A LV 970128 A LV970128 A LV 970128A LV 970128 A LV970128 A LV 970128A LV 11899 A LV11899 A LV 11899A
Authority
LV
Latvia
Prior art keywords
derivatives
adenozine
consequence
acquisition
new
Prior art date
Application number
LV970128A
Other languages
English (en)
Other versions
LV11899B (lv
Inventor
Nicole Bru-Magniez
Timur Gungor
Jean-Marie Teulon
Original Assignee
Union Pharma Scient Appl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union Pharma Scient Appl filed Critical Union Pharma Scient Appl
Publication of LV11899A publication Critical patent/LV11899A/lv
Publication of LV11899B publication Critical patent/LV11899B/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
LVP-97-128A 1992-01-08 1997-06-25 Jauni adenozīna atvasinājumi, to iegūšanas paņēmiens LV11899B (lv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9200138A FR2685918B1 (fr) 1992-01-08 1992-01-08 Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.

Publications (2)

Publication Number Publication Date
LV11899A true LV11899A (lv) 1997-12-20
LV11899B LV11899B (lv) 1998-03-20

Family

ID=9425478

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-97-128A LV11899B (lv) 1992-01-08 1997-06-25 Jauni adenozīna atvasinājumi, to iegūšanas paņēmiens

Country Status (25)

Country Link
US (2) US5229505A (lv)
EP (1) EP0623138B1 (lv)
JP (1) JP3224542B2 (lv)
KR (1) KR100232672B1 (lv)
AT (1) ATE153342T1 (lv)
AU (1) AU661894B2 (lv)
CA (1) CA2127472C (lv)
CZ (1) CZ289047B6 (lv)
DE (1) DE69219901T2 (lv)
DK (1) DK0623138T3 (lv)
EE (1) EE03087B1 (lv)
ES (1) ES2105285T3 (lv)
FI (1) FI106205B (lv)
FR (1) FR2685918B1 (lv)
GE (1) GEP19981357B (lv)
GR (1) GR3024386T3 (lv)
HU (1) HU221304B1 (lv)
LV (1) LV11899B (lv)
MD (1) MD502G2 (lv)
NZ (1) NZ246904A (lv)
RU (1) RU2129560C1 (lv)
SK (1) SK282205B6 (lv)
TW (1) TW254945B (lv)
UA (1) UA44221C2 (lv)
WO (1) WO1993014102A1 (lv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2685918B1 (fr) * 1992-01-08 1995-06-23 Union Pharma Scient Appl Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.
FR2714907B1 (fr) * 1994-01-07 1996-03-29 Union Pharma Scient Appl Nouveaux dérivés de l'Adénosine, leurs procédés de préparation, compositions pharmaceutiques les contenant.
WO1995018817A1 (fr) * 1994-01-07 1995-07-13 Laboratoires Upsa Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant
TW528755B (en) 1996-12-24 2003-04-21 Glaxo Group Ltd 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
FR2772271B1 (fr) * 1997-12-11 2000-09-01 Union Pharma Scient Appl Nouvelle association pharmaceutique a activite analgesique
YU44900A (sh) 1998-01-31 2003-01-31 Glaxo Group Limited Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola
NZ509030A (en) 1998-06-23 2003-07-25 Glaxo Group Ltd 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
JP2002173427A (ja) * 1998-09-01 2002-06-21 Yamasa Shoyu Co Ltd 眼疾患治療用医薬組成物
DE19924818A1 (de) * 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäureamide
ATE425738T1 (de) * 1999-11-17 2009-04-15 Boston Scient Ltd Miniaturisierte vorrichtungen zur abgabe von molekulen in einer tragerflussigkeit
WO2002020539A1 (fr) * 2000-09-08 2002-03-14 Toa Eiyo Ltd. Derives d'adenosine et leur utilisation
EP1352910A1 (en) * 2002-04-10 2003-10-15 Grünenthal GmbH New analogs of nitrobenzylthioinosine
PE20060272A1 (es) 2004-05-24 2006-05-22 Glaxo Group Ltd (2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE788958A (fr) * 1971-09-18 1973-03-19 Schering Ag Derives d'adenosine et leur procede de preparation
US4167565A (en) * 1976-11-08 1979-09-11 Abbott Laboratories Adenosine-5'-carboxamides and method of use
US5310731A (en) * 1984-06-28 1994-05-10 Whitby Research, Inc. N-6 substituted-5'-(N-substitutedcarboxamido)adenosines as cardiac vasodilators and antihypertensive agents
US4755594A (en) * 1986-01-31 1988-07-05 Warner-Lambert Company N6 -substituted adenosines
JPH0696534B2 (ja) * 1986-04-25 1994-11-30 ヘキストジヤパン株式会社 抗痴呆剤
AU8276187A (en) * 1986-10-31 1988-05-25 Warner-Lambert Company Selected n6-substituted adenosines having selective a2 binding activity
AU8274187A (en) * 1986-10-31 1988-05-25 Warner-Lambert Company Heteroaromatic derivatives of adenosine
EP0267878A1 (en) * 1986-11-14 1988-05-18 Ciba-Geigy Ag N9-cyclopentyl-substituted adenine derivatives
SU1661367A1 (ru) * 1988-11-01 1991-07-07 Всесоюзный научно-исследовательский институт по креплению скважин и буровым растворам Способ гидрофобизации тампонажных материалов
DE69123974T2 (de) * 1990-09-25 1997-05-07 Rhone-Poulenc Rorer International (Holdings) Inc., Greenville, Del. Verbindungen welche antihypertensive und antiischemische eigenschaften besitzen
FR2685918B1 (fr) * 1992-01-08 1995-06-23 Union Pharma Scient Appl Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
JP3224542B2 (ja) 2001-10-29
CZ289047B6 (cs) 2001-10-17
EP0623138A1 (fr) 1994-11-09
SK81894A3 (en) 1995-04-12
MD502G2 (ro) 1996-11-30
RU2129560C1 (ru) 1999-04-27
EP0623138B1 (fr) 1997-05-21
HUT68095A (en) 1995-05-29
ES2105285T3 (es) 1997-10-16
FI943222A (fi) 1994-08-18
DE69219901T2 (de) 1997-11-13
FI106205B (fi) 2000-12-15
CZ164394A3 (en) 1995-02-15
KR100232672B1 (ko) 1999-12-01
DE69219901D1 (de) 1997-06-26
WO1993014102A1 (fr) 1993-07-22
LV11899B (lv) 1998-03-20
MD502F1 (en) 1996-03-29
CA2127472C (en) 2003-11-18
AU3455093A (en) 1993-08-03
FI943222A0 (fi) 1994-07-06
SK282205B6 (sk) 2001-12-03
UA44221C2 (uk) 2002-02-15
CA2127472A1 (en) 1993-07-22
DK0623138T3 (da) 1997-12-15
HU9402040D0 (en) 1994-09-28
US5480983A (en) 1996-01-02
FR2685918A1 (fr) 1993-07-09
RU94039545A (ru) 1997-04-27
EE03087B1 (et) 1998-04-15
GR3024386T3 (en) 1997-11-28
JPH07502738A (ja) 1995-03-23
GEP19981357B (en) 1998-08-25
FR2685918B1 (fr) 1995-06-23
ATE153342T1 (de) 1997-06-15
HU221304B1 (en) 2002-09-28
NZ246904A (en) 1995-04-27
TW254945B (lv) 1995-08-21
AU661894B2 (en) 1995-08-10
US5229505A (en) 1993-07-20

Similar Documents

Publication Publication Date Title
DK0597088T3 (da) Nye imidazolderivater, deres fremstilling og terapeutiske anvendelser
LV11899A (lv) Jauni adenozina atvasinajumi to iegusanas panemiens
EP0482410A3 (en) Anti-microbial compounds, including substituted 2-cyclohexyl-amine derivatives and their preparation
ATE137402T1 (de) Retinoid enthaltende dermatologische und/oder kosmetische zusammensetzungen
SE9402880D0 (sv) New peptide derivatives
CS9100438A2 (en) New derivative of beta-phenylisoserine, method of its preparation and its application
GR3020330T3 (en) Novel bicyclic pyrimidine compounds, method for preparing same and pharmaceutical compositions containing said compounds.
MX9203100A (es) Nuevos peptidos, su preparacion y su aplicacion.
ES2124256T3 (es) Arilmorfolina, preparacion y uso.
PT775143E (pt) Novos derivados de 3h-2,3-benzodiazepina 3-substituidos sua preparacao e utilizacao
MX9303605A (es) Derivados de azabicicloheptano n-substituidas, su obtencion y uso.
ATE163402T1 (de) Substituierte ortho- ethenylphenylessigsäurederivate
ATE138662T1 (de) Antibiotische 7-aminonaphthazarinderivate
SE9401596D0 (sv) New compounds
FI960588A0 (fi) Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä